Literature DB >> 16574062

Factors affecting the performance of different long terminal repeats in the retroviral vector.

Sujeong Kim1, Karim Lee, Mi-Dong Kim, Seock Kang, Chang Wan Joo, Jong-Mook Kim, Seon Hee Kim, Seung Shin Yu, Sunyoung Kim.   

Abstract

The long terminal repeat (LTR) of retrovirus contains the nucleotide sequences that control gene expression. Although several different LTRs have been used in the context of retroviral vector, the activity of the various LTRs has not yet been systematically compared for their level of gene expression. We evaluated the effect of four different LTRs on gene expression using luciferase, stem cell factor, and enhanced green fluorescence protein as reporter genes. LTRs tested in this study were derived from Moloney murine leukemia virus, myeloproliferative sarcoma virus, murine stem cell virus, and spleen focus-forming virus. It was found that the level of gene expression is affected by not only LTRs but also the transgenes and the cell types in which gene expression occurs. Furthermore, the presence of other nucleotide sequences such as the internal ribosome entry site (IRES)-neo cassette could also significantly affect gene expression. Our results suggested that the LTR should be chosen carefully, more or less on an empirical basis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574062     DOI: 10.1016/j.bbrc.2006.03.035

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Nonintegrating foamy virus vectors.

Authors:  David R Deyle; Yi Li; Erik M Olson; David W Russell
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

2.  A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression.

Authors:  Sachiko Okamoto; Yasunori Amaishi; Yumi Goto; Hiroaki Ikeda; Hiroshi Fujiwara; Kiyotaka Kuzushima; Masaki Yasukawa; Hiroshi Shiku; Junichi Mineno
Journal:  Mol Ther Nucleic Acids       Date:  2012-12-18       Impact factor: 10.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.